Tonix sues Dr. Reddy's over generic TONMYA patent challengeNov 13Regulatory decisioncyclobenzaprineTonix Pharmaceuticals, Inc.
Tonix posts $15 million in TONMYA sales for Q3, cites pipeline progressNov 9Quarterly updatecyclobenzaprineTonix Pharmaceuticals, Inc.
Tonix reports preliminary TONMYA revenue of $14.0M to $15.0M for Q3 2026Oct 15Quarterly updatecyclobenzaprineTonix Pharmaceuticals, Inc.
Tonix receives Paragraph IV challenge against TONMYA patents from Dr. Reddy'sOct 2Regulatory decisioncyclobenzaprineTonix Pharmaceuticals, Inc.
Tonix reports Q2 2026 results, TONMYA sales rise 197%, HORIZON trial beginsAug 10Quarterly updatecyclobenzaprineTonix Pharmaceuticals, Inc.
Tonix enrolls first patient in Phase 2 depression trial of TNX-102 SLJun 29Trial updatecyclobenzaprineTonix Pharmaceuticals, Inc.